Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice-Reference-Cited by-同舟云学术

Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice

Published:2022-12-01 Issue:2 Volume:384 Page:306-314
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Davis Sarah E.^ORCID,Ferris Mark J.,Ananthan Subramaniam,Augelli-Szafran Corinne E.,Zhu Jun

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference71 articles.

1. Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study

2. Restoration of KCC2 Membrane Localization in Striatal Dopamine D2 Receptor-Expressing Medium Spiny Neurons Rescues Locomotor Deficits in HIV Tat-Transgenic Mice;Barbour;ASN Neuro,2021

3. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors

4. HIV dementia: the role of the basal ganglia and dopaminergic systems

5. Cerebrospinal fluid dopamine in HIV-1 infection

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter;International Journal of Molecular Sciences;2024-07-18

2. HIV‐1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over time;Journal of Neurochemistry;2024-02-03

3. The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases;International Journal of Molecular Sciences;2023-10-19

4. Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions;Brain, Behavior, and Immunity;2023-10